61 related articles for article (PubMed ID: 4333669)
1. Tumor-specific antigen solubilized by hypertonic potassium chloride.
Meltzer MS; Leonard EJ; Rapp HJ; Borsos T
J Natl Cancer Inst; 1971 Sep; 47(3):703-9. PubMed ID: 4333669
[No Abstract] [Full Text] [Related]
2. Generation of tumor-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumor cells and recombinant interleukin-2.
Harada M; Matsuzaki G; Shinomiya Y; Kurosawa S; Ito O; Okamoto T; Takenoyama M; Sumitika H; Nishimura Y; Nomoto K
Cancer Immunol Immunother; 1994 May; 38(5):332-8. PubMed ID: 8162615
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulins associated with human tumours in vivo: IgG concentrations in eluates of colonic carcinomas.
MacSween JM; Eastwood SL
Br J Cancer; 1980 Oct; 42(4):503-9. PubMed ID: 7437286
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour.
Sunba MS; Rahi AH; Morgan G; Holborow EJ
Br J Ophthalmol; 1980 Aug; 64(8):576-90. PubMed ID: 7426575
[No Abstract] [Full Text] [Related]
5. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
Müller S; Ernst TM
Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
[TBL] [Abstract][Full Text] [Related]
6. Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats.
Lando P; Berzins K; Gabriel J; Larsson P; Perlmann P
Br J Cancer; 1981 Oct; 44(4):522-31. PubMed ID: 7295508
[TBL] [Abstract][Full Text] [Related]
7. The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.
Apuzzo ML; Sheikh KM; Weiss MH; Heiden JS; Kurze T
Acta Neurochir (Wien); 1981; 55(3-4):181-200. PubMed ID: 7015801
[TBL] [Abstract][Full Text] [Related]
8. The kinetics of T lymphocyte subpopulations in guinea-pigs sensitized with allogeneic transplantation antigens.
Hashim GA; Yee N; Ramey WG
Clin Exp Immunol; 1980 Sep; 41(3):533-40. PubMed ID: 6969158
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum blocking factors on leucocyte adherence inhibition and PHA lymphocyte blastogenesis in breast cancer patients.
Fujisawa T; Yonemoto RH; Waldman SR
Jpn J Surg; 1981; 11(6):406-12. PubMed ID: 6799680
[TBL] [Abstract][Full Text] [Related]
10. A human tumour-associated membrane antigen from squamous-cell carcinoma of the lung.
Veltri RW; Maxim PE; Boehlecke JM
Br J Cancer; 1980 May; 41(5):705-15. PubMed ID: 6775653
[TBL] [Abstract][Full Text] [Related]
11. Transfer factor in restoration of cell mediated immunity in lung cancer patients.
Fujisawa T; Yamaguchi Y; Kimura H
Jpn J Surg; 1983 Jul; 13(4):304-11. PubMed ID: 6606065
[TBL] [Abstract][Full Text] [Related]
12. Tumor-reactive IgE antibodies in plasma of patients with gastrointestinal carcinomas.
Berczi I; Holford-Strevens V; Warsi ZH; McMorris LS; Thorlakson RH; Thorlakson TK; Sehon AH
Cancer Immunol Immunother; 1983; 14(3):180-4. PubMed ID: 6551192
[TBL] [Abstract][Full Text] [Related]
13. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS
Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio).
Paque RE; Gauntt CJ; Nealon TJ
Infect Immun; 1981 Jan; 31(1):470-9. PubMed ID: 6260666
[TBL] [Abstract][Full Text] [Related]
15. MS-related material in blood of multiple sclerosis patients: results with the leucocyte adherence inhibition assay.
Lehmitz R; Meyer U; Meyer-Rienecker HJ
J Neurol; 1983; 229(4):263-6. PubMed ID: 6192228
[TBL] [Abstract][Full Text] [Related]
16. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Hoffmann W; Werner W; Steiner R; Kaufmann R
Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
[TBL] [Abstract][Full Text] [Related]
17. A study of methods for producing cell-free tumour antigen from BP8 mouse ascites tumour.
Davies EG; Cater DB
Br J Exp Pathol; 1973 Oct; 54(5):583-9. PubMed ID: 4758387
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers.
Thomson DM; Sellens V; Eccles S; Alexander P
Br J Cancer; 1973 Nov; 28(5):377-88. PubMed ID: 4758368
[TBL] [Abstract][Full Text] [Related]
19. A cross-reacting embryonic antigen in the membrane of rat sarcoma cells which is immunogenic in the syngeneic host.
Thomson DM; Alexander P
Br J Cancer; 1973 Jan; 27(1):35-47. PubMed ID: 4631228
[TBL] [Abstract][Full Text] [Related]
20. A common tumour specific antigen. II. Further characterization of the whole antigen and of a cross-reacting antigen of normal tissues.
Dickinson JP; McDermott JR; Smith JK; Caspary EA
Br J Cancer; 1974 Jun; 29(6):425-32. PubMed ID: 4527605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
